Antiretroviral therapy intensification for HIV-associated neurocognitive disorder?

AIDS. 2023 Nov 1;37(13):2095-2096. doi: 10.1097/QAD.0000000000003694. Epub 2023 Sep 28.

Authors

Bruce J Brew¹, David B Clifford²

Affiliations

¹ Departments of Neurology and HIV Medicine and Peter Duncan Neurosciences Unit St Vincent's Hospital, University of New South Wales and Notre Dame, Sydney, New South Wales, Australia.
² Department of Neurology, Washington University School of Medicine, St Louis, Missouri, USA.

PMID: 37755427
DOI: 10.1097/QAD.0000000000003694

No abstract available

Publication types

Comment

MeSH terms

AIDS Dementia Complex* / drug therapy
Anti-HIV Agents* / therapeutic use
Antiretroviral Therapy, Highly Active
HIV Infections* / complications
HIV Infections* / drug therapy
Humans
Neurocognitive Disorders / drug therapy
Neuropsychological Tests

Substances

Anti-HIV Agents